French animal health group Ceva has withdrawn a legal challenge to a tender to supply avian flu vaccine to France, in which it lost out to Germany’s Boehringer Ingelheim. France chose Boehringer Ingelheim to supply 80 million doses of bird flu vaccine needed for its first vaccination campaign in ducks, due to start in October. The plan will make France the first country in the European Union to vaccinate poultry against the virus that has ravaged flocks worldwide. Ceva has decided to drop its appeal against the outcome of the tender in order to avoid any delay in the vaccination campaign for the livestock sector, the company said in a statement late last week. The company is continuing discussions with the authorities on subsequent phases of the vaccination campaign and has already produced more than 10 million shots of its avian influenza vaccine for ducks, Ceva added.
